Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Blocking certain proteins on immune cells may help treat alopecia areata.

A comprehensive human skin cell atlas was created to better understand skin biology and disease.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

CD44 variant changes start alopecia areata, but don't maintain it.

Cells from skin and lung can help regenerate hair follicles.

Telocytes in silky fowl embryos develop distinct features and connections by the 20th day of incubation.

CEC levels may be a useful marker for predicting prostate cancer progression.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

A new lab-grown lung model helps study adenoviruses and test antiviral drugs.

ECM1-modified stem cells can effectively treat liver cirrhosis.

A new method helps grow skin stem cells better, which could improve skin grafts for burn victims.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

The new assay can help develop products for hair re-growth.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.